Here is Why Growth Investors Should Buy Vistra (VST) Now
ZACKS· 2024-11-27 02:45
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the ...
3 Reasons Why Growth Investors Shouldn't Overlook Booz Allen (BAH)
ZACKS· 2024-11-27 02:45
文章核心观点 - 文章讨论了Booz Allen Hamilton (BAH)作为潜在增长股票的吸引力,强调了其强劲的财务增长和有利的Growth Score,以及Zacks Rank 2的评级 [2][9][11] 公司分析 盈利增长 - 公司的历史每股收益(EPS)增长率为13%,而今年的预期EPS增长率为12.8%,远超行业平均的6.2% [4] 现金流增长 - 公司目前的年度现金流增长率为14.6%,高于行业平均的8.2% [5] - 过去3-5年的年度现金流增长率为13.6%,也高于行业平均的11.2% [6] 盈利预测修正 - 公司当前年度的盈利预测在过去一个月内上调了0.7%,显示出积极的趋势 [7] 行业对比 盈利增长 - 行业平均的EPS增长率为6.2%,低于Booz Allen Hamilton的12.8% [4] 现金流增长 - 行业平均的现金流增长率为8.2%,低于Booz Allen Hamilton的14.6% [5] - 行业过去3-5年的平均现金流增长率为11.2%,低于Booz Allen Hamilton的13.6% [6]
CLASS ACTION NOTICE: Berger Montague Advises Evolv Technologies (NASDAQ: EVLV) Investors to Inquire About a Securities Fraud Class Action
GlobeNewswire News Room· 2024-11-27 02:41
文章核心观点 - Evolv Technologies Holdings, Inc. (Evolv) 因财务报表中的重大错误和内部人员的不当行为,面临投资者的集体诉讼 [1][4] 公司背景 - Evolv 是一家总部位于马萨诸塞州沃尔瑟姆的安全技术公司,利用基于人工智能的筛选技术帮助创造更安全的体验 [3] 事件时间线 - 2024年10月25日,Evolv 宣布其2022年第二季度至2024年第二季度的财务报表不应被依赖,因为存在影响收入确认的重大错误 [4] - 2024年10月31日,Evolv 宣布立即解雇其CEO Peter George [6] 财务影响 - 2024年10月25日,Evolv 股价下跌约40%,从每股4.10美元跌至2.47美元 [5] - 2024年10月31日,Evolv 股价再次下跌约8%,从每股2.34美元跌至2.15美元 [6] 法律行动 - 投资者可以在2024年12月31日前申请成为集体诉讼的主要原告 [3] - 投资者可以通过联系 Berger Montague 了解更多关于诉讼的信息 [6] 公司回应 - Evolv 已将这些问题自报给美国证券交易委员会 [4] - Evolv 解雇了其CEO Peter George [6]
ANTERIX TO PRESENT AT JANNEY CLEAN ENERGY INVESTMENT SYMPOSIUM DECEMBER 4-5, 2024
Prnewswire· 2024-11-27 02:40
WOODLAND PARK, N.J., Nov. 26, 2024 /PRNewswire/ -- Anterix (NASDAQ: ATEX) Chief Operating Officer Ryan Gerbrandt will participate in a panel discussion related to the 900 MHz private wireless broadband revolution and its impact on helping our nation's utilities transform critical infrastructure. This panel will be held on December 5, 2024, from 2:30 p.m. - 3:20 p.m., during Janney's 2nd Annual Clean Energy Investment Symposium, taking place in New Orleans, LA.Additionally, Anterix Vice Chairman Tom Kuhn wil ...
Deutsche Bank sees higher inflation in 2025 if tariffs go ahead
Proactiveinvestors NA· 2024-11-27 02:38
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Starwood Property: A 10% Yield You Shouldn't Give Up
Seeking Alpha· 2024-11-27 02:38
文章核心观点 - 文章由一名资深金融研究员撰写,专注于创新和颠覆性技术以及成长型收购和价值股票的投资机会 [1] 分析师披露 - 分析师持有STWD股票的长期受益头寸,包括股票所有权、期权或其他衍生品 [2] 平台披露 - 过去的表现不能保证未来的结果,文章不构成任何投资建议 [3]
Mereo BioPharma: Setrusumab Chugs Along With Possible Inflection Points
Seeking Alpha· 2024-11-27 02:36
文章核心观点 - 文章由Terry Chrisomalis发布,他是Biotech Analysis Central制药服务的主理人,该服务提供对多家制药公司的深入分析 [1] - 文章作者拥有一个包含600多篇生物科技投资文章的库,以及一个包含10多只中小市值股票的模型投资组合,每只股票都有深入分析 [2] 服务内容 - 提供600多篇生物科技投资文章的库 [2] - 包含10多只中小市值股票的模型投资组合,每只股票都有深入分析 [2] - 提供实时聊天功能 [2] - 提供各种分析和新闻报告,帮助医疗保健投资者做出明智决策 [2] 订阅信息 - Biotech Analysis Central SA市场服务每月收费49美元,但年度订阅用户可享受33.50%的折扣,年费为399美元 [1] - 目前提供两周免费试用期 [1]
End of Year Rally: 3 Stocks to Watch (IDCC, FUTU, EXEL)
ZACKS· 2024-11-27 02:35
As the calendar winds down, the stock market often heats up. The last five weeks of the year have historically shown a bullish seasonal pattern, fueled by holiday optimism, institutional portfolio adjustments, and a tendency for investors to position themselves for the upcoming year. This "Santa Claus rally" can provide lucrative opportunities for investors who know where to look.Combining this favorable market seasonality with the Zacks Rank—a proven stock-picking strategy rooted in earnings estimate revis ...
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Xerox Holdings Corporation. Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
GlobeNewswire News Room· 2024-11-27 02:28
文章核心观点 - 罗森律师事务所宣布代表在2024年1月25日至2024年10月28日期间购买了Xerox Holdings Corporation(纳斯达克代码:XRX)证券的投资者提起集体诉讼 [1] 诉讼详情 - 诉讼指控Xerox在集体诉讼期间发布了虚假和/或误导性的声明,未能披露以下事实: - 在大幅裁员后,Xerox的销售团队进行了重组,包括新的区域分配和账户覆盖 [5] - 这导致Xerox的销售团队生产力受到干扰 [5] - 因此,Xerox的旧产品销售率下降 [5] - 清理旧产品的困难将推迟关键产品的发布 [5] - 因此,Xerox的销售和收入可能会下降 [5] - 这些因素导致Xerox关于其业务、运营和前景的正面声明具有误导性或缺乏合理依据 [5] 投资者行动 - 在集体诉讼期间购买Xerox证券的投资者可能有权获得赔偿,无需支付任何费用或成本 [2] - 投资者可以通过访问https://rosenlegal.com/submit-form/?case_id=31433或联系Phillip Kim律师(电话:866-767-3653,邮箱:case@rosenlegal.com)加入Xerox集体诉讼 [3][6] - 投资者可以选择自己的律师,也可以选择不采取任何行动,作为缺席的集体成员 [7] 罗森律师事务所介绍 - 罗森律师事务所鼓励投资者选择具有成功领导经验的合格律师 [4] - 罗森律师事务所在证券集体诉讼和股东衍生诉讼方面有丰富的经验,并在2017年ISS证券集体诉讼服务排名中名列第一 [4] - 罗森律师事务所的律师多次被Lawdragon和Super Lawyers认可 [4]
Rivian locks in US government loan for Georgia EV plant construction
Proactiveinvestors NA· 2024-11-27 02:25
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...